Product supply and coordination
Active Pharmaceutical Ingredients for development and manufacturing.
High-quality APIs, with access to R&D, manufacturing and regulatory documentation support in China.
Explore productsProducts
Our portfolio covers a wide range of therapeutic categories.
Company Overview
Sijia Pharm is a China-based supplier of APIs, advanced intermediates, excipients, and reference standards. We provide strong regulatory support (DMF / ASMF / CEP) and accompany clients from development to commercial supply with technical expertise and reliable service.
3,000 m² · 90 employees · more than 60 R&D personnel for novel products (CRO/CDMO)
5,000 m² · 30+ reactors · 112,700 L total volume
Product supply and coordination
3,000 m² · 90 employees · more than 60 R&D personnel for novel products (CRO/CDMO)
5,000 m² · 30+ reactors · 112,700 L total volume
R&D Centre
A 3,000 m² centre supporting customised production of intermediates and APIs from gram to ton, novel product process development and optimisation, and multi-variety inventory reserves.
Analytical equipment
HPLC, GC, Karl Fischer moisture analysis, potentiometric titration, stability study and LCMS.
Process capabilities
Asymmetric catalytic reduction, metal-coupling reactions, low-temperature butyllithium reactions and amination.
Production Site
A 5,000 m² multi-purpose modular workshop supporting flexible scale-up and commercial production of pharmaceutical intermediates and APIs.
Reactor configuration
500, 1,000, 2,000, 3,000, 4,000, 5,000 and 6,300 L reactors in glass-lined steel, stainless steel and Hastelloy.
Specific processes
Hydrogenation up to 10 MPa, chlorination, fluorination, amination and ultra-low-temperature reactions.


Quality & Regulatory
EP, USP, CP and in-house standards.
Contact
